skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

もっと見る

Resources

もっと見る

もっと見る

Products

もっと見る

もっと見る

99+ Total results for product and free and sample content found

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

The 14 Billion Dose COVID-19 Manufacturing Challenge

VaccinateTheWorld_Getty_1250

Manufacturing COVID-19 vaccines at unprecedented speed and scale is 2021’s biggest challenge – and mRNA platforms are emerging as the leaders, living up to their promise as the ideal technology for pandemic preparedness.

Medtech Insight: 世界の医療機器・医療技術の最新情報

Dangerous Endotoxins Lead To Class I Recall For Medtronic Device Used On Pediatric Patients

Medtronic_2_1200

The US FDA on 24 March gave its highest risk designation to a recall of the company’s Affinity Pixie Oxygenator and Cardiotomy/Venous Reservoir. The device is used on newborns, infants and small pediatric patients undergoing a cardiopulmonary bypass procedure.

Medtech Insight: 世界の医療機器・医療技術の最新情報

GE Healthcare Makes Entry Into Handheld Ultrasound Device Ring

Vscan-air

GE Healthcare has announced the launch of Vscan Air, its first wireless ultrasound device.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Dunad Makes Debut In Protein Degradation Space

US_dollars_1200x675

Based in Cambridge UK, Dunad believes it has developed a platform which is "tuneable and highly selective" and represents a new and differentiated targeted protein degradation approach.

HBW Insight : コンシューマーヘルスケア産業のニュース

Is The Tide Turning For EU Prebiotics And Probiotics Regulation?

EuropeGlobe_dencg_478321069_1200x675

More EU countries than you might think allow the terms "prebiotic" and "probiotic" on food supplement labels, suggests a survey from consultancy firm Sandwalk Bioventures. HBW Insight speaks to Sandwalk's managing director, Luis Gosalbez, about a possible move towards liberalization in the region among member states, as well as a way forward for EU regulators lagging behind this localized movement. 

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Quick Listen: Scrip’s Five Must-Know Things

SC2008_FiveMustKnowThings_1200_Final

In this week's podcast version of Five Must-Know Things, hear about new results for Lilly in Alzheimer’s, a US delay for AbbVie, progress for Zolgensma in the UK, challenges for AstraZeneca’s coronavirus vaccine, and a Scrip roundtable on industry lessons from the pandemic.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Moderna Not Immune To COVID-19 Effects On Trials

 Moderna Not Immune To COVID-19 Effects On Trials

Company suspends enrolment to trials as coronavirus travel restrictions bite.

Topic Coronavirus

Generics Bulletin: ジェネリック&バイオシミラーニュース

Pfizer Breaks With Biosimilars In China Through WuXi Bio Deal

China_globe_1200x675

Pfizer has announced plans to put a lid on its biosimilars programs in China, while agreeing the sale of its manufacturing site in Hangzhou.

世界の薬事規制動向&情報を配信

Real-World Evidence On COVID 19 Vaccines Coming Into US FDA

PS210317-House_Commerce_Hearing

Peter Marks says agency is getting first RWE readouts of vaccine safety; AstraZeneca’s vaccine has no expiration date, so stockpile is not currently at risk of being thrown out, the CBER director tells a House hearing.

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問合せの際は下記メールアドレスまたは各営業スタッフまでご連絡下さいますようご協力をお願い申し上げます。

インフォーマインテリジェンス合同会社
ファーマインテリジェンス
inquiry.jp@informa.com

*Omdia(ICT産業の情報)に関するお問い合わせはこちら
Contact_OmdiaJapan@omdia.com


オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。